Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Osmind provides a commercial-stage electronic health record and analytics platform tailored to psychiatry/mental health practices. Their system enables collection of high-quality real-world data at scale. Published results include one of the largest real-world analyses of ketamine therapy for depression in collaboration with Stanford Medicine, showing a significant effectiveness rate (~54%) in treatment-resistant patients and reduction in suicidal ideation post-treatment. The company’s dataset supports translational research, clinical development design/recruitment, medical affairs/HEOR studies, safety monitoring/REMS automation, and commercialization activities for novel psychiatric therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Osmind.